UBS Group’s Arbor Rapha Capital Bioholdings Corp. I Units ARCKU Stock Holding History

UBS Group’s Portfolio ARCKU Stock Details ARCKU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-899	Closed	-$9K	–	11560
2022 Q3	$9K	Hold	899	–	–	﹤0.01%	8664
2022 Q2	$9K	Hold	899	–	–	﹤0.01%	8239
2022 Q1	$9K	Hold	899	–	–	﹤0.01%	8614
2021 Q4	$9K	Buy	+899	New	+$9.09K	﹤0.01%	8976

Other funds holding ARCKU

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group's ARCKU Position: Q4 2022 in Review

UBS Group sold out of Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) in Q4 2022, closing a stake of 899 shares — an estimated $9K sold.

UBS Group first reported a position in ARCKU in Q4 2021 and held it in 4 quarters. The position peaked at $9K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCKU as of Q4 2022.

UBS Group reported no remaining Arbor Rapha Capital Bioholdings Corp. I Units position as of Q4 2022 after selling out during the quarter.
UBS Group sold 899 Arbor Rapha Capital Bioholdings Corp. I Units shares in Q4 2022, an estimated $9K.
UBS Group first reported a position in Arbor Rapha Capital Bioholdings Corp. I Units in Q4 2021 and held it in 4 quarters.
UBS Group's Arbor Rapha Capital Bioholdings Corp. I Units position peaked at $9K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Units as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.